FI931414L - Imidazolderivat, foerfarande foer deras framstaellning samt deras anvaendning i terapi - Google Patents

Imidazolderivat, foerfarande foer deras framstaellning samt deras anvaendning i terapi Download PDF

Info

Publication number
FI931414L
FI931414L FI931414A FI931414A FI931414L FI 931414 L FI931414 L FI 931414L FI 931414 A FI931414 A FI 931414A FI 931414 A FI931414 A FI 931414A FI 931414 L FI931414 L FI 931414L
Authority
FI
Finland
Prior art keywords
deras
terapi
imidazolderivat
anvaendning
foerfarande foer
Prior art date
Application number
FI931414A
Other languages
English (en)
Finnish (fi)
Other versions
FI931414A7 (fi
FI931414A0 (fi
Inventor
Pierre Dodey
Michel Bondoux
Patrice Renaut
Didier Pruneau
Original Assignee
Fournier Ind & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante
Publication of FI931414A0 publication Critical patent/FI931414A0/fi
Publication of FI931414A7 publication Critical patent/FI931414A7/fi
Publication of FI931414L publication Critical patent/FI931414L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/62Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with triarylmethyl radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI931414A 1992-04-01 1993-03-29 Imidazolderivat, foerfarande foer deras framstaellning samt deras anvaendning i terapi FI931414L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR929203944A FR2689508B1 (fr) 1992-04-01 1992-04-01 Derives de l'imidazole, leur procede de preparation et leur application en therapeutique.

Publications (3)

Publication Number Publication Date
FI931414A0 FI931414A0 (fi) 1993-03-29
FI931414A7 FI931414A7 (fi) 1993-10-02
FI931414L true FI931414L (fi) 1993-10-02

Family

ID=9428340

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931414A FI931414L (fi) 1992-04-01 1993-03-29 Imidazolderivat, foerfarande foer deras framstaellning samt deras anvaendning i terapi

Country Status (13)

Country Link
EP (1) EP0564356A1 (enrdf_load_stackoverflow)
JP (1) JPH06263743A (enrdf_load_stackoverflow)
KR (1) KR930021622A (enrdf_load_stackoverflow)
CN (1) CN1081438A (enrdf_load_stackoverflow)
AU (1) AU3554693A (enrdf_load_stackoverflow)
CA (1) CA2092852A1 (enrdf_load_stackoverflow)
FI (1) FI931414L (enrdf_load_stackoverflow)
FR (1) FR2689508B1 (enrdf_load_stackoverflow)
HU (1) HUT64752A (enrdf_load_stackoverflow)
MX (1) MX9301882A (enrdf_load_stackoverflow)
NO (1) NO931186L (enrdf_load_stackoverflow)
TW (1) TW232012B (enrdf_load_stackoverflow)
ZA (1) ZA932351B (enrdf_load_stackoverflow)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015817A (en) * 1996-12-05 2000-01-18 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
UA71587C2 (uk) * 1998-11-10 2004-12-15 Шерінг Акцієнгезелльшафт Аміди антранілової кислоти та їхнє застосування як лікарських засобів
DE10023486C1 (de) * 2000-05-09 2002-03-14 Schering Ag Ortho substituierte Anthranilsäureamide und deren Verwendung als Arzneimittel
US20060167269A1 (en) * 2001-07-11 2006-07-27 Hamilton Andrew D Compounds and methods for the inhibition of compounds cruzi
US7615565B2 (en) 2002-07-31 2009-11-10 Bayer Schering Pharma Aktiengesellschaft VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
UA89035C2 (ru) * 2003-12-03 2009-12-25 Лео Фарма А/С Эфиры гидроксамовых кислот и их фармацевтическое применение
EP1657241A1 (en) 2004-11-03 2006-05-17 Schering Aktiengesellschaft Novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors
EP1655295A1 (en) 2004-11-03 2006-05-10 Schering Aktiengesellschaft Anthranilamide pyridinureas as VEGF receptor kinase inhibitors
US7906533B2 (en) 2004-11-03 2011-03-15 Bayer Schering Pharma Ag Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
EP1752450A1 (en) 2005-08-01 2007-02-14 Merck Sante Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them
EP2162441B1 (en) 2007-05-24 2016-01-06 Eldrug S.A. 1,(3,)5-substituted imidazoles, useful in the treatment of hypertension and methods for their preparation
WO2009016514A2 (en) * 2007-08-01 2009-02-05 Eldrug S.A. 1, 3 and 1, 3, 5 substituted imidazoles as antihypertensiva
GR1006917B (el) * 2007-10-24 2010-07-30 Ελληνικα Φαρμακα Ερευνα Και Αναπτυξη Eldrug Α.Ε., Ανταγωνιστες του υποδοχεα της αγγειοτενσινης ιι με βαση την ισταμινη (και παραγωγα αυτης) με ιδιοτητες καταστολης του συμπαθητικου συστηματος και συνθετικες μεθοδοι στη θεραπεια της υπερτασης και αλλων καρδιοαγγειακων ασθενειων.
PA8840701A1 (es) 2008-08-27 2010-04-21 Leo Pharma As NUEVO RECEPTOR VEGF-2 e INHIBIDORES DE PROTEÍNAS TIROSINA QUINASA Y SU USO FARMACÉUTICO DE LOS MISMOS
CN102584709B (zh) * 2011-12-19 2016-08-17 浙江华海药业股份有限公司 一种改进的依普罗沙坦中间体芳基咪唑醛的制备工艺
JP7197880B2 (ja) * 2017-10-19 2022-12-28 学校法人 名城大学 エステル化剤及びその利用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2110663B (en) * 1981-12-04 1985-08-07 Farmos Group Ltd Imidazole derivatives
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
EP0403158A3 (en) * 1989-06-14 1991-12-18 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
DK0403159T3 (da) * 1989-06-14 2000-08-14 Smithkline Beecham Corp Imidazolylalkensyrer
AU640417B2 (en) * 1989-10-25 1993-08-26 Smithkline Beecham Corporation Substituted 5-((tetrazolyl)alkenyl)imidazoles
CA2028925A1 (en) * 1989-11-06 1991-05-07 Gerald R. Girard Substituted n-(imidazolyl)alkyl alanine derivatives
GB8927928D0 (en) * 1989-12-11 1990-02-14 Roussel Lab Ltd Chemical compounds
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,

Also Published As

Publication number Publication date
MX9301882A (es) 1994-06-30
JPH06263743A (ja) 1994-09-20
NO931186D0 (no) 1993-03-30
ZA932351B (en) 1994-10-03
AU3554693A (en) 1993-10-07
HUT64752A (en) 1994-02-28
NO931186L (no) 1993-10-04
FI931414A7 (fi) 1993-10-02
KR930021622A (ko) 1993-11-22
FI931414A0 (fi) 1993-03-29
CN1081438A (zh) 1994-02-02
TW232012B (enrdf_load_stackoverflow) 1994-10-11
HU9300942D0 (en) 1993-06-28
EP0564356A1 (fr) 1993-10-06
CA2092852A1 (en) 1993-10-02
FR2689508B1 (fr) 1994-06-17
FR2689508A1 (fr) 1993-10-08

Similar Documents

Publication Publication Date Title
FI934460A7 (fi) Karboxylsyraderivat, laekemedel innehaollande dessa foereningar samt foerfaranden foer deras framstaellning
FI924963L (fi) Staerkelsefibrer, foerfarande foer deras framstaellning samt deras anvaendning
FI933274L (fi) Tvaerbundna, kvaevehaltiga vinylkopolymerer, foerfarande foer framstaellning av dessa samt anvaendning av dessa
FI922955L (fi) Foerfarande foer framstaellning av utfaelld kiseldioxid, utfaellda kiseldioxider samt deras anvaending foer foerstaerkning av elastomerer
FI935296L (fi) Elektronisk osynlig markering avsedd foer saekerhetspaosar, ett foerfarande foer maerkning samt ett foerfarande foer detektering
FI935260A7 (fi) Telekommunikationssystem, i vilket debiteringsdatan registreras i handtelefonen
FI932999A7 (fi) Foerfarande foer lageravdragning, lageravdragare samt anvaendning daerav
FI934610A0 (fi) Ventilsammansaettning foer roerledning, omfattande loestagbart ventilsaete
FI921459L (fi) Piperidinderivat, framstaellning av dessa samt terapeutisk anvaendning av dessa
FI931414L (fi) Imidazolderivat, foerfarande foer deras framstaellning samt deras anvaendning i terapi
FI89753B (fi) Foerfarande foer kontroll av en betalanordning foer parkering, en betalanordning samt en anordning foer kontroll av densamma
FI932516A7 (fi) Styrkonsol, i synnerhet foer motorfordon
FI931747A0 (fi) Reflexkropp, isynnerhet foer vaegmarkeringar
FI932720L (fi) Barriaerfilm samt foerfarande foer framstaellning daerav
FI925825L (fi) Substituerade pyridin-n-oxider, foerfarande foer framstaellning av dessa samt anvaendning av dessa
FI923709A0 (fi) I en saekerhetsskena laosbar vagn.
FI933408L (fi) Ksylanas, ksylanas producerande bacillus-stammar samt deras utnyttjande
FI934343L (fi) Bensimidazoler, laekemedel innehaollande dessa foereningar samt foerfaranden foer deras framstaellning
FI924791L (fi) Xantatdisulfidgrupper innehaollande polymerer, foerfarande foer deras framstaellning samt deras anvaendning
FI931825A7 (fi) Hydraulisk tryck- och draganordning, speciellt foer jaernvaegsskenor
FI921481A0 (fi) Faestning av smygmonteringskran samt monteringsfoerfarande.
FI934317L (fi) Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen
FI923703L (fi) Foerfarande foer identifiering av en signalvaeg, samt signalbehandlingsapparat
FI932595L (fi) En vattenhaltig, polymerisk, viskositet upphoejande komposition
FI922527A0 (fi) Vaeggkonstruktion foer anordning i byggnader.

Legal Events

Date Code Title Description
FD Application lapsed